CAS 1951431-22-3

BKI-1369

Description:

BKI-1369, identified by its CAS number 1951431-22-3, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds like BKI-1369 are typically evaluated for their biological activity, mechanism of action, and pharmacokinetic properties. It is often studied for its role in modulating specific biological pathways, which may include interactions with enzymes or receptors relevant to disease processes. Additionally, safety and toxicity profiles are crucial for understanding its suitability for further development. As research progresses, detailed information regarding its efficacy, optimal dosing, and potential side effects will become available, contributing to its overall characterization as a candidate for drug development. For precise data, including structural formulas and experimental results, consulting specialized databases or scientific literature is recommended.

Formula: C₂₃H₂₇N₇O

Synonyms:

• BKI-1369
• BKI1369,BKI 1369

BKI-1369

CAS: 1951431-22-3

BKI-1369 is an experimental drug in the class of benzimidazole derivatives that is being studied for use in the treatment of infectious diseases. It has been shown to have a broad spectrum of activity against bacteria and protozoa, including multidrug-resistant strains. BKI-1369 has been successful in animal studies with peroxides, which are toxic compounds generated by some bacteria. It has been shown to be active against c. parvum and intestinal-dwelling bacteria such as E. coli and Enterococcus faecalis. Clinical trials have demonstrated that BKI-1369 is effective in treating mucosal lesions caused by Chlamydia pneumoniae, Mycoplasma hominis, or C. parvum in humans or animals. This drug targets the enzyme thymidine phosphorylase, which is essential for bacterial growth and replication.

Formula: C₂₃H₂₇N₇O

Purity: Min. 95%

Molecular weight: 417.51 g/mol

Ref: 3D-BDD43122

BKI-1369

CAS: 1951431-22-3

BKI-1369 is a bumped kinase inhibitor. BKI-1369 increases hERG-inhibitory activity (IC50:1.52 μM).

Formula: C₂₃H₂₇N₇O

Color and Shape: Solid

Molecular weight: 417.51

Ref: TM-T10556